Institut Pasteur, a private foundation recognised of public utility, developed some research which made it possible to identify the HIV-1/VIH retrovirus which is responsible for AIDS, and to define…
The new edition of the bestseller The Annotated European Patent Convention (Derk Visser, 2010) will be published on paper on 15 December 2010, but is already available for subscribers on www…
The Enlarged Board of Appeal answered the question referred to it by the Board of Appeal in J 2/08.
The Enlarged Board of Appeal held that after a decision to refuse a European patent application,…
European patent practitioners are welcoming the news that the EPO Administrative Council reached a decision on 26 October 2010 to extend the period for responding to a communication under Rule 161…
In Grimme Landmaschinenfabrik GmbH v Scott [2010] EWCA Civ 1110 the English Court of Appeal stated clearly its support for judicial collaboration facilitating de facto harmonisation of patent law in…
In decision G2/08, available on the EPO website, the Enlarged Board of Appeal provides a problem in relation to the Swiss type claims. It announces the abolition of the use of these claims in point 7…
When challenging the validity of a patent, a decision needs to be made early on as to grounds on which to rely. When it comes to allegations of anticipation and obviousness, the challenger and its…
The company Laboratoires Medidom (hereinafter referred to as “Medidom”) is the holder of European patent No. 520 414, entitled “Process for the preparation of diacetylrhein”, which concerns “a…
Unilever NV (hereinafter referred to as “Unilever”) is the holder of a European patent filed in English on 19 March 2001 and the grant of which was published in the European Patent Bulletin dated…